Silybum marianum (milk thistle) and its main constituent, silymarin, as a potential therapeutic plant in metabolic syndrome: A review
Meta-analysis / review
Abstract
This review examines Silybum marianum and silymarin as a potential therapeutic plant in metabolic syndrome, covering its effects on obesity, dyslipidemia and diabetes, supporting its antidiabetic use.
Referenced for these plants
How to cite
Tajmohammadi, A., Razavi, B.M. and Hosseinzadeh, H (2018) 'Silybum marianum (milk thistle) and its main constituent, silymarin, as a potential therapeutic plant in metabolic syndrome: A review', Phytotherapy Research, 32(10), pp. 1933-1949. doi:10.1002/ptr.6153
This reference is part of the evidence base for the Omnia Sana plant database. Source links open the original publication; Omnia Sana does not host third-party content.